You are on page 1of 42

Inflammatory Heart Disease (IHD)

Marye G.

May, 2021

05/23/2021 IHD 1
OUTLINES
• Definition

• Etiology and risk factors

• Pathophysiology

• Clinical manifestation

• Diagnostic modalities

• Management and prevention

• Complications
05/23/2021
IHD
2
Objectives
At the end of this presentation, we will be able to:

Define pericarditis, myocarditis and endocarditis

Identify cause and risk factors

 Describe common clinical manifestations

 List differential diagnosis

Explain medical and nursing managements


Inflammatory Heart Diseases
• The inflammation of the heart muscles, the membrane
sac which surrounds the heart, or the inner lining of the
heart is known as inflammatory heart diseases. These
includes:

o Infective Endocarditis

o Myocarditis

o Pericarditis
05/23/2021 IHD 4
INFECTIVE ENDOCARDITIS

05/23/2021 IHD 5
Definition
• Endocarditis is an inflammation of the inner layer of the
heart, the endocardium.

• It usually involves the valves and other structures like the

intraventricular and the septum.

• IE is an infection of the endocardial surface of the heart.

• The intracardiac effects of this infection include severe


valvular insufficiency, which may lead to intractable
congestive heart failure and myocardial abscesses.
05/23/2021 IHD 6
Etiologies
• Although bacteria remain the most common etiology,
virtually all organisms (including viruses, fungi, and

rickettsia) can cause endocarditis.

05/23/2021 IHD 8
Risk factors
• Advanced age • Heart surgery
• Acute rheumatic fever • Intubations
• Congenital heart disease
• Procedures involving GI &
• Previous heart damage GU

• Dental procedures • Reproductive conditions


like delivery of new babies,
abortions and PID

05/23/2021 IHD 9
Pathophysiology
• Pathogens gain access to the bloodstream  Pathogens adhere
to an area of abnormal cardiac valve surface  Pathogens,
such as S. aureus, obtain intracellular access to the valve
endothelium  The infected vegetation is created by burying
of the proliferating organism within a protective matrix of
serum molecules  Vegetation particles can detach and
disseminate to form emboli  These may lead to
complications such as ischemic stroke, mycotic aneurysms
and infarcts or abscesses at remote sites. 
05/23/2021 IHD 10
Classification
• Depending on the type of valve affected
1. Native valve endocarditis (NVE)

 The commonest type of Infective endocarditis in


Ethiopia and other developing countries.

 Endocarditis that may develop on natural valve.

 The affected valve may be damaged.

05/23/2021 IHD 11
2. Prosthetic valve endocarditis
Is when the endocarditis develops on prosthetic/’artificial’ valve.

There is a marked rise in cases of prosthetic valve endocarditis and


endocarditis in IV drug abusers in different parts of the world.

3. Endocarditis in intravenous drug abuser (IVDA)


Intravenous (IV) drug users are at very high risk of acute
endocarditis, because numerous needle punctures give aggressive Staph
bacteria many opportunities to enter the blood through broken skin.

Dirty drug administering equipments increases the risk.

If untreated, this form of endocarditis can be fatal in < 6 weeks.


05/23/2021 IHD 12
• Depending on the clinical course
A. Acute Infective endocarditis:

Frequently involves healthy valves.

It is a rapidly progressive illness with destruction of


valvular structures.

B. Subacute Infective endocarditis:

Typically affects only previously damaged valves.

The course is insidious even in untreated cases which may


extend over many months.
05/23/2021 IHD 13
Etiologic agent of Infective endocarditis
• Streptococcus viridans: is a normal flora of the oral cavity.

It accounts for 50-60% of cases of subacute infective


endocarditis.

• Group D streptococci: found in the gastrointestinal or


genitourinary tract.

Most cases infective endocarditis due to this organism is


subacute.

05/23/2021 IHD 14
Cont…
• S. aureus: is the leading cause of Prosthetic valve
endocarditis (PVE), acute infective endocarditis and
endocarditis in IV drug abusers.

• Approximately 35-60.5% of staphylococcal bacteremia is


complicated by infective endocarditis.

In more than half of cases endocarditis due to S. aureus


occurs in the absence of underlying valvular disease.

 Mortality rate may range 40-50%.


05/23/2021 IHD 15
Clinical manifestations
 Fever and Shortness of breath
Murmurs
 Clubbing of fingers
Splinter Hemorrhage
Osler’s nodes
Janeway’s lesions
 Shock
 Finger clubbing
 Weight loss, Malaise, Chills, Night sweats
 Chest and abdominal pain
 Anorexia
05/23/2021 IHD 16
Splinter Hemorrhage

05/23/2021
IHD 21
Diagnostic evaluations
 History and physical examination

 Blood culture and white blood cell count: leukocytosis

 Urinalysis: microscopic hematuria

 Computerized tomography rule out heart damage

 BUN and creatinine levels to evaluate renal function

 Echocardiography: for valvular and ventricular function

 Chest x-ray
05/23/2021 IHD 22
Differential Diagnosis
• Lyme Disease-an acute inflammation of joints with fever

• Systemic Lupus Erythematosus

• Polymyalgia Rheumatica

• Primary Cardiac Neoplasms

• Reactive Arthritis

05/23/2021 IHD 26
Medical management
• Administer oxygen therapy

• Administer antibiotic treatment like ampicillin +

flucloxacillin +gentamicin

• Administer paracetamole 1g po as analgesic

• Administer inotropic drugs like digoxin

• Morphine to decrease anxiety

05/23/2021 IHD 27
Specific Antibiotics treatment
Native valve endocarditis (NVE)
•Crystalline penicillin 3-4 million IU IV every 4 hours for 4- 6 weeks plus

Gentamicin 1mg/kg ( 80 mg ) IV TID for 2 weeks for synergistic coverage of


streptococci.

Prosthetic valve endocarditis (PVE); due to MRSA


•Vancomycin 1gm IV BID for 6 weeks Plus

Gentamicin 1mg/kg ( 80 mg ) IV TID for 2 weeks plus


Refampicin 300 mg PO /TID for 6 weeks

Patients with a history of IV drug use


05/23/2021 IHD 28
Complications

Chronic heart failure

Shock

 Stroke

Embolism

05/23/2021 IHD 30
Myocarditis

05/23/2021 IHD 32
Definition
• Myocarditis is inflammation of the myocardium often
resulting from infectious process, which subsequently leads
to myocardial destruction and a dilated cardiomyopathy.

• Can be produced by a variety of different disorders, many of


which are infectious.

• Viral infection is the most frequently identified cause of


myocarditis.

• Myocarditis may be acute or chronic.


05/23/2021 IHD 33
Etiologies of Myocarditis
1. Infectious causes
Viral infections : is the most common cause, enterovirus
(Coxsackie virus B), HIV myocarditis (10 % of HIV pts).

Bacterial, Fungal and Protozoal infections

Rickettsia: associated with Typhus

Spirochetes: associated with Relapsing fever.

2. Immune mediated: Hypersensitivity and autoantigens

3. Toxic substances: Heavy metals, ethanol and Radiation


05/23/2021 IHD 34
Classification
• Fulminant myocarditis - presents with acute heart failure
up to 2 weeks after a distinct viral infection.

Patients have severe cardiovascular compromise with


ventricular dysfunction.

Multiple foci of active myocarditis are typical; either


resolves spontaneously or results in death.

• Acute myocarditis - Less distinct onset of illness, with


established ventricular dysfunction; may progress to dilated
cardiomyopathy
05/23/2021 IHD 36
Pathophysiology

• Virus invades the muscle cause local inflammation

• Body's immune system inflict inflammatory damage

• Myocyte degeneration or necrosis

• Cardiomegaly and diminished systolic function occur

due to myocardial damage.

• CHF, shock, arrythmias and sudden death.


05/23/2021 IHD 38
Clinical Presentations
History
• The clinical presentation of myocarditis is variable.

• The typical time interval between the onset of the viral illness and
cardiac involvement is 2 weeks.

• Fever is present in 20% of cases.


• Chest pain (pleuritic, squeezing, sharp stabbing) is reported in 35% of
cases.

• Dyspnea, fatigue, sweating, chills

• Palpitations and syncope are common.


• Sudden cardiac death
05/23/2021 IHD 40
Physical Examination
• Tachycardia, gallop, mitral regurgitation, edema

• Acute rheumatic fever - Usually affects heart in 50-90%;


associated signs, such as erythema marginatum,
polyarthralgia, chorea, subcutaneous nodules (Jones
criteria)

• Hypersensitive myocarditis - Pruritic maculopapular rash


and history of using offending drug

05/23/2021 IHD 42
Diagnostic modalities
Laboratory Studies:
• CBC - Leukocytosis is present in 25% of cases.

• ESR - is elevated in 60% of patients with acute myocarditis.

• C-reactive protein

• Elevated cardiac enzymes - Creatine kinase or cardiac troponins

• Serum viral antibody titers - For viral myocarditis

Chest x-ray

Echocardiography

ECG
05/23/2021 IHD 43
Management
• Low sodium diet

• Digoxin: should be given with caution as patients with


myocarditis are sensitive for digitalis toxicities.

• Sympathomimetic and beta-blocker drugs should be


avoided because they increase the extent of myocardial
necrosis and mortality.

05/23/2021 IHD 44
Cont….
Pharmacotherapy

• Medications used in the management of myocarditis


include the following:
• Penicillin for hemolytic streptococci
• Vasodilators (eg, nitroglycerin, sodium nitroprusside)
• ACE inhibitors (eg, enalapril)
• Angiotensin receptor blocking agents
• Anti inflammatory drugs
05/23/2021 IHD 45
Complications
• Chronic Heart Failure: due to injured heart muscle

• Pericarditis

• Cardiomyopathy

• Arrhythmia: sudden unexpected, potentially fatal heart


rhythm abnormalities

• Death: myocarditis may cause sudden death in some


patients without medical attention during acute illness.

05/23/2021 IHD 49
PERICARDITIS

05/23/2021 IHD 51
Definition
• An inflammation of the pericardium, membranous sac
enveloping the heart.

• It may be a primary illness, or it may develop in the course


of a variety of medical and surgical disorders.

• Pericarditis may be acute ,sub acute and chronic

• Classified by the layers of the pericardium becoming


attached to each other (adhesive) or by what accumulates
in the pericardial sac: serum (serous), pus (purulent),
calcium deposits (calcific), clotting proteins (fibrinous)
05/23/2021 IHD 52
Etiology

• Idiopathic or viral — 42 to 49 %

• Post cardiac surgery — 11 to 37 %

• Post radiation therapy — 9 to 31 %

• Connective tissue disorder — 3 to 7 %

• Postinfectious (tuberculous or purulent pericarditis) 3


to 6 %

• Miscellaneous causes (malignancy, trauma, drug-


induced, sarcoidosis, uremic (pericarditis) — 1 to 10 %
05/23/2021 IHD 54
Pathologically pericarditis can be classified

1. Effusive pericarditis

2. Effusive constriction pericarditis

3. Constrictive pericarditis

4. Adhesive forms

05/23/2021 IHD 58
Clinical Manifestations

The most characteristic symptom is chest pain (pleuritic

chest pain)

Sharp, severe substernal pain or to the left of sternum

Pain may be felt in epigastrium and may be referred to

neck, arms, and back and may worsen with deep

inspiration and when lying down.

Pain relieved with a forward leaning or sitting position.


05/23/2021 IHD 63
Cont…

The most characteristic sign is a friction rub.

Other signs mild fever, increased WBC count and ESR.

Other signs and symptoms of constrictive pericarditis or


cardiac tamponade:-
• Hypotension, and tachycardia
• Pulsus paradoxus
• Raised JVP
• Distant heart sounds
• Ascites, hepatomegaly
05/23/2021 IHD 64
Diagnostic Modalities
There is no single test that is diagnostic for pericarditis.

The ECG is the most reliable diagnostic tool.

Patient’s history and Signs/symptoms

Physical examination: the hallmark of acute pericarditis is


the pericardial friction rub.

Chest x-ray

Echocardiogram: may detect inflammation and fluid


build-up, as well as indications of heart failure, and help to
confirm the diagnosis.
05/23/2021 IHD 65
Management
Bed rest until the fever, chest pain, and friction rub have
subsided.

Analgesics and NSAIDs (aspirin/ibuprofen)

Corticosteroids, if the pericarditis is severe or if the patient


does not respond to NSAIDs.

Pericardiocentesis or Pericardiotomy

A pericardial window, a small opening made in the


pericardium, may be performed to allow continuous
drainage into the chest cavity.
05/23/2021 IHD 68
Rx out come
• The clinical course of pericarditis is variable:

• 60% of patients have complete recovery within 1 week, and

• Almost 80% have complete recovery within 3 weeks.

• Eighteen percent(18%) of patients can have recurrent


pericarditis

Complications

• Cardiac tamponade

• Constrictive pericarditis
05/23/2021 IHD 71
THANK YOU
questions ???

05/23/2021 IHD 73

You might also like